Appointment is a Signal of CPSI’s Commitment to Physician Adoption of Healthcare Information Technology in Small and Rural Communities
MOBILE, Ala.--(BUSINESS WIRE)--Oct. 13, 2016-- CPSI (NASDAQ: CPSI), a leading provider of healthcare information solutions, today announced that William J. Hayes, M.D. has joined the Company as a Medical Director with its Physician Adoption team.
As part of the Physician Adoption team, Dr. Hayes will focus on improving the user experience rural providers have with all CPSI solutions. He will work with fellow CPSI Medical Director, Ron Louks, MD and MBA, collaborating with physicians across the CPSI family of companies. Leveraging existing client channels such as the CPSI Physician Council, Early Adopter and Pilot programs, the Physician Adoption team is focused on ensuring clinical solutions are aligned to meet their needs and preferences when it comes to workflows, training, and education specific to physicians.
“Bill Hayes brings additional experience to our organization and to our focused efforts to align our products and services with the unique needs of rural physicians,” said Boyd Douglas, president and chief executive officer of CPSI. “Physician Adoption is critical to the success of community healthcare. Representing the interests of our client physicians and consulting directly with them will be an important role for Dr. Hayes.”
Anticipating his new role, Dr. Hayes said, “I am looking forward to working with CPSI and Dr. Louks as an advocate for physicians who are dedicated to improving population health in their communities. I am proud to be representing the voices of thousands of physicians. I think we can make real progress by addressing the unique challenges in rural America and making it easier for physicians to do what they do best, which is keeping their patients healthy.”
In addition to his M.D. from Rutgers University’s Robert Wood Johnson Medical School, Dr. Hayes completed his MBA from the Mitchell College of Business at the University of South Alabama. He has also been a Fellow of the American College of Cardiology. Dr. Hayes’ most recent experience has been as a Physician Executive with Cerner Corporation in Kansas City, Medical Director of Cardiovascular Diagnostic Services for Internal Medicine Center in Mobile, as well as an Executive Physician Consultant for Eclipsys Corporation of Atlanta. He has held several other executive positions and was a partner/owner of Cardiology Associates PC of Mobile, where he practiced cardiology and critical care medicine at five hospitals. He was previously a Chief Cardiology Fellow at Texas Heart Institute.
CPSI is a leading provider of healthcare IT solutions and services for rural and community hospitals and post-acute care facilities. Founded in 1979, CPSI is the parent of five companies – Evident, LLC, TruBridge, LLC, Healthland Inc., American HealthTech, Inc., and Rycan Technologies, Inc. Our combined company is focused on helping improve the health of the communities we serve, connecting communities for a better patient care experience, and improving the financial operations of our customers. Evident provides comprehensive EHR solutions and services for rural and community hospitals. TruBridge focuses exclusively on providing business management, consulting and managed IT services to rural and community healthcare organizations, regardless of their IT vendor. Healthland provides integrated technology solutions and services to small rural and critical access hospitals. American HealthTech is one of the nation's largest providers of financial and clinical technology solutions and services for post-acute care facilities. Rycan provides revenue cycle management and workflow and automation software to hospitals, healthcare systems, and skilled nursing organizations. For more information, visit www.cpsi.com, www.evident.com, www.trubridge.com, www.healthland.com, www.healthtech.net or www.rycan.com.
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as "expects," "anticipates," "estimates," "believes," "predicts," "intends," "plans," "potential," "may," "continue," "should," "will" and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates and future financial results are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors may include: overall business and economic conditions affecting the healthcare industry, including the potential effects of the federal healthcare reform legislation enacted in 2010, and implementing regulations, on the businesses of our hospital customers; government regulation of our products and services and the healthcare and health insurance industries, including changes in healthcare policy affecting Medicare and Medicaid reimbursement rates and qualifying technological standards; changes in customer purchasing priorities, capital expenditures and demand for information technology systems; saturation of our target market and hospital consolidations; general economic conditions, including changes in the financial and credit markets that may affect the availability and cost of credit to us or our customers; our substantial indebtedness, and our ability to incur additional indebtedness in the future; our inability to generate sufficient cash in order to meet our debt service obligations; restrictions on our current and future operations because of the terms of our senior secured credit facilities; market risks related to interest rate changes; our ability to successfully integrate the businesses of Healthland, American HealthTech and Rycan with our business and the inherent risks associated with any potential future acquisitions; competition with companies that have greater financial, technical and marketing resources than we have; failure to develop new or enhance current technology and products in response to market demands; failure of our products to function properly resulting in claims for losses; breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation; failure to maintain customer satisfaction through new product releases or enhancements free of undetected errors or problems; interruptions in our power supply and/or telecommunications capabilities, including those caused by natural disaster; our ability to attract and retain qualified customer service and support personnel; failure to properly manage growth in new markets we may enter; misappropriation of our intellectual property rights and potential intellectual property claims and litigation against us; changes in accounting principles generally accepted in the United States; fluctuations in quarterly financial performance due to, among other factors, timing of customer installations; and other risk factors described from time to time in our public releases and reports filed with the Securities and Exchange Commission, including, but not limited to, our most recent Annual Report on Form 10-K. We also caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date of this press release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161013005228/en/
Tracey Schroeder, 612-787-3125
Chief Marketing Officer